Cancer Genetics Issues Letter to Shareholders

20 Feb 2020 - Yahoo News
RUTHERFORD, N.J., Feb. 20, 2020 -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics” or the “Company”), a leader in drug discovery and preclinical oncology and.
usx:cgix

---

Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update

20 Nov 2019 - Yahoo News
RUTHERFORD, N.J., Nov. 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced.
usx:cgix

---

Introducing Cancer Genetics (NASDAQ:CGIX), The Stock That Collapsed 98%

14 Nov 2019 - Yahoo News
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. For example, we sympathize with...
usx:cgix

---

Cancer Genetics, Inc. Announces Strategic Transactions

24 Oct 2019 - Yahoo News
Cancer Genetics, Inc. (CGIX), a leader in proprietary preclinical test systems supporting drug discovery and development at early stages, valued by the pharmaceutical industry, biotechnology companies and academic research centers, today announced, among others, the completion of several strategic transactions. ...
usx:cgix

---

Cancer Genetics Announces 1-for-30 Reverse Stock Split

24 Oct 2019 - Yahoo News
Cancer Genetics, Inc. (CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The reverse stock split is intended to increase the per share trading price of Cancer Genetics’ ...
usx:cgix

---

Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners

17 Oct 2019 - Yahoo News
Interpace Diagnostics Group, Inc. (IDXG) announced today that it has closed on a $13 million Convertible Preferred Stock investment by Ampersand Capital Partners (Ampersand). This investment constitutes the second tranche of the overall $27 million Convertible Preferred Stock financing provided by Ampersand ...
usx:cgix

---

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

20 Aug 2019 - Yahoo News
RUTHERFORD, N.J., Aug. 20, 2019 -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced.
usx:cgix

---

Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ

16 Jul 2019 - Nasdaq
Top Health Care StocksTop Health Care Stocks JNJ 1 58 JNJ 1 58 PFE 0 23 PFE 0 23 ABT 0 95 ABT 0 95 MRK 0 65 MRK 0 65 AMGN 0 82 AMGN 0 82 Health care stocks fell Tuesday with the NYSE Health Care Index dropping almost 0 4 while shares of health care companies in the S amp P 500
usx:cgix

---

Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ

16 Jul 2019 - Nasdaq
Top Health Care StocksTop Health Care Stocks JNJ 1 26 JNJ 1 26 PFE 0 21 PFE 0 21 ABT 0 73 ABT 0 73 MRK 0 41 MRK 0 41 AMGN 0 42 AMGN 0 42 Health care stocks were falling this afternoon with the NYSE Health Care Index dropping almost 0 4 while shares of health care companies in
usx:cgix

---

Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit

16 Jul 2019 - Yahoo News
Cancer Genetics (NASDAQ: CGIX ) shares are trading sharply higher after Interpace Diagnostics (NASDAQ: IDXG ) said it purchased the Biopharma Services unit of the Cancer Genetics. Interpace Diagnostics ...
usx:cgix

---